Latest News and Press Releases
Want to stay updated on the latest news?
-
Delhi, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Kuick Research announces the release of its latest study on the US Orphan Drug Market, offering investors, venture capital firms, and equity strategists a...
-
Ottawa, Sept. 30, 2025 (GLOBE NEWSWIRE) -- The global rare disease treatment market size was valued at USD 195.21 billion in 2024 and is predicted to hit around USD 587.08 billion by 2034, rising at...
-
Covina, Aug. 30, 2024 (GLOBE NEWSWIRE) -- According to Prophecy Market Insights, the global rare disease market size and share value is projected to grow from USD 161.4 Billion in 2020 and is...
-
Delhi, June 30, 2023 (GLOBE NEWSWIRE) -- Global Orphan Drugs Market & Clinical Trials Insight Report 2028 Highlights: Clinical Insight On More Than 600 Marketed Orphan DrugsClinical Insight On...
-
Jersey City, NJ, May 10, 2023 (GLOBE NEWSWIRE) -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Rare Disease Clinical Trials Market Size, Share...
-
Singapore, June 25, 2022 (GLOBE NEWSWIRE) -- Global Orphan Drugs Market & Clinical Trials Insight Report 2028 Highlights: Clinical Insight On More Than 600 Marketed Orphan DrugsClinical...
-
Singapore, May 19, 2022 (GLOBE NEWSWIRE) -- Global Orphan Drugs Market & Clinical Trials Insight Report 2028 Highlights: Clinical Insight On More Than 600 Marketed Orphan DrugsClinical...
-
Singapore, May 18, 2022 (GLOBE NEWSWIRE) -- Global Orphan Drugs Market & Clinical Trials Insight Report 2028 Highlights: Clinical Insight On More Than 600 Marketed Orphan DrugsClinical...
-
Visiongain has published a new report on “Rare Disease Market Forecast 2021-2031: By Drugs (Revlimid, MabThera/Rituxan, Opdivo, Imbruvica, Sprycel, Tasigna, Copaxone,Rebif, Gleevec, Velcade, Others),...
-
Delhi, Nov. 23, 2021 (GLOBE NEWSWIRE) -- Global Orphan Drugs Clinical Trials Insight Report Highlights: Clinical Insight On More Than 400 Marketed Orphan DrugsClinical Insight On More Than 1300...